Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Chemokine Receptor 2 Is A Theranostic Biomarker for Abdominal Aortic Aneurysms
Santiago Elizondo-Benedetto, Sergio Sastriques-Dunlop, Lisa Detering, et al.
Cancer Research
|
October 4, 2018
A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in Glioblastoma
Joanna L Birch, Karen Strathdee, Lesley Gilmour, et al.
JACC. Basic to Translational Science
|
April 24, 2025
Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms
Santiago Elizondo-Benedetto, Sergio Sastriques-Dunlop, Lisa Detering, et al.
Cancer Research
|
February 1, 2018
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer
Mathieu Unbekandt, Simone Belshaw, Justin Bower, et al.
Nature Communications
|
February 16, 2017
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
Juan R Hernandez-Fernaud, Elena Ruengeler, Andrea Casazza, et al.
Cell Reports
|
September 15, 2021
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging
Alessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.
Cancer Discovery
|
December 17, 2020
MNK Inhibition Sensitizes <i>KRAS</i>-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression
John R P Knight, Constantinos Alexandrou, George L Skalka, et al.
Nature
|
September 3, 2025
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target
Sanna N Masud, Anchal Srivastava, Patricia Mero, et al.
American Journal of Human Genetics
|
October 1, 2025
A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B
Esra Erkut, Cherith Somerville, Marci L B Schwartz, et al.
Nature
|
December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Stephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Chemokine Receptor 2 Is A Theranostic Biomarker for Abdominal Aortic Aneurysms
Santiago Elizondo-Benedetto, Sergio Sastriques-Dunlop, Lisa Detering, et al.
Cancer Research
|
October 4, 2018
A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in Glioblastoma
Joanna L Birch, Karen Strathdee, Lesley Gilmour, et al.
JACC. Basic to Translational Science
|
April 24, 2025
Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms
Santiago Elizondo-Benedetto, Sergio Sastriques-Dunlop, Lisa Detering, et al.
Cancer Research
|
February 1, 2018
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer
Mathieu Unbekandt, Simone Belshaw, Justin Bower, et al.
Nature Communications
|
February 16, 2017
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
Juan R Hernandez-Fernaud, Elena Ruengeler, Andrea Casazza, et al.
Cell Reports
|
September 15, 2021
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging
Alessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.
Cancer Discovery
|
December 17, 2020
MNK Inhibition Sensitizes <i>KRAS</i>-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression
John R P Knight, Constantinos Alexandrou, George L Skalka, et al.
Nature
|
September 3, 2025
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target
Sanna N Masud, Anchal Srivastava, Patricia Mero, et al.
American Journal of Human Genetics
|
October 1, 2025
A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B
Esra Erkut, Cherith Somerville, Marci L B Schwartz, et al.
Nature
|
December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Stephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.
Page
of 7